January 3, 2022
16,367
647
170
4.99%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
11:47Now PlayingThe United States faces a shortage of rapid COVID-19 tests amid the Omicron surge even as many inexpensive at-home rapid testing models have been ready for distribution — but refused approval by the U.S. Food and Drug Administration. One scientist, Harvard-trained Irene Bosch, submitted a rapid test to the FDA for emergency approval in March 2020 and even had a factory ready to produce it. Bosch describes how the FDA’s rejection came from unclear standards set by the administration early on in the pandemic, and says earlier approval of testing like hers could have saved lives.
#DemocracyNow
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 89AM ET
Please consider supporting independent media by making a donation to Democracy Now! today
FOLLOW DEMOCRACY NOW! ONLINE:
Daily Email Digest
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.